Search Results - "Pamplona" :: UTM Library Massive Scholar Tracking

4761

Virtual antenna array for reduced energy per bit transmission at Sub-5 GHz mobile wireless communication systems by Mohammad Alibakhshikenari, Bal Virdee, Dion Mariyanayagam, Ignacio Garcia Zuazola, Haralambos Harry Benetatos, Ayman A. Althuwayb, Bader Alali, Kai-Da Xu, Francisco Falcone

Published 2023-05-01

Get full text

Article

4762

Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors by Gonzalez-Torres MA, Salazar MA, Imaz M, Inchausti L, Ibañez B, Fernandez-Rivas A, Pastor J, Anguiano B, Muñoz P, Ruiz E, Oraa R, Bustamante S, Alvarez de Eulate S, Cisterna R

Published 2015-06-01

“…Miguel Angel Gonzalez-Torres,1,2 Miguel Angel Salazar,3 Manuel Imaz,4 Lucía Inchausti,1,2 Berta Ibañez,5 Aranzazu Fernandez-Rivas,1,2 Javier Pastor,3 Bosco Anguiano,3 Pedro Muñoz,3 Eduardo Ruiz,1,2 Rodrigo Oraa,3 Sonia Bustamante,1,2 Sofia Alvarez de Eulate,2 Ramón Cisterna4,61Department of Neuroscience, University of the Basque Country, 2Psychiatry Service, Basurto University Hospital, Bilbao, 3Mental Health Network of Biscay, Basque Health Service, Biscay, 4Microbiology Service, Basurto University Hospital, Bilbao, 5Navarra Biomed-Miguel Servet Foundation, Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Pamplona, 6Department of Microbiology, University of the Basque Country, Bilbao, SpainBackground: The aims of this study were to evaluate the prevalence of HIV and its associated demographic and clinical factors among psychiatric inpatients of a general hospital.Methods: This was a single-center, observational, cross-sectional study that included patients consecutively admitted to our unit aged 16 years or older and with no relevant cognitive problems. …”

Get full text

Article

4763

Guía de Práctica Clínica para el manejo nutricional de personas con Fibrosis Quística (GPC-FQ) by María Garriga, Adriana Horrisberger, Arantza Ruiz de las Heras de la Hera, Natalia Catalán, Gloria Fernández, Marta Suárez, Nuria Porras, Laura Monje

Published 2017-04-01

Get full text

Article

4764

Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study by Sofía Montemayor, Cristina Bouzas, Catalina M. Mascaró, Miguel Casares, Isabel Llompart, Itziar Abete, Escarlata Angullo-Martinez, María Ángeles Zulet, J. Alfredo Martínez, Josep A. Tur

Published 2022-05-01

Get full text

Article

4765

Factores relevantes de capital humano en Instituciones de Educación Superior en Colombia by Ana-Milena García-Mogollón, Javier-Mauricio García-Mogollón, Elizabeth Malagon-Saenz

Published 2023-04-01

Get full text

Article

4766

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized,... by Coghill DR, Banaschewski T, Lecendreux M, Soutullo C, Zuddas A, Adeyi B, Sorooshian S

Published 2014-10-01

“…David R Coghill,1 Tobias Banaschewski,2 Michel Lecendreux,3 César Soutullo,4 Alessandro Zuddas,5 Ben Adeyi,6 Shaw Sorooshian7 1Division of Neuroscience, University of Dundee, Dundee, UK; 2Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 3Paediatric Sleep Centre and National Reference Centre for Orphan Diseases: Narcolepsy, Idiopathic Hypersomnia and Kleine-Levin Syndrome, Robert-Debré University Hospital, Paris, France; 4Child and Adolescent Psychiatry Unit, Department of Psychiatry and Medical Psychology, University of Navarra Clinic, Pamplona, Spain; 5Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy; 6Shire, Wayne, PA, USA; 7Shire, Eysins, Switzerland Background: Following the approval of lisdexamfetamine dimesylate (LDX) in several European countries for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents with an inadequate response to methylphenidate (MPH) treatment, the aim of the present analysis was to establish the response to LDX in subgroups of patients with different ADHD medication histories. …”

Get full text

Article

4767